SCHEMBL1301323

SCHEMBL1301323

CN1CCN(CCCOC(=O)Cl)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 7/20 0.49
DRD3 P35462 2/20 0.49
PAOX Q6QHF9 1/20 0.49
RAB9A P51151 2/20 0.46
SLC29A1 Q99808 2/20 0.43
ALDH1A1 P00352 4/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
KDM4E B2RXH2 2/20 0.43
POLB P06746 1/20 0.43
RAD52 P43351 1/20 0.43
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ABCC4 O15439 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
TSHR P16473 1/20 0.40
CHRM3 P20309 1/20 0.40
HTR2A P28223 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1950623 0.98 HRH3 (0.48) HRH3DRD3PAOXRAB9ASLC29A1
SCHEMBL10388024 0.93 HRH3 (0.46) HRH3DRD3PAOXRAB9ASLC29A1
Hydrochloric Acid SCHEMBL3107158 0.91 PAOX (0.53) HRH3DRD3PAOXRAB9ASLC29A1
SCHEMBL10387010 0.89 ALDH1A1 (0.49) HRH3DRD3PAOXRAB9ASLC29A1
SCHEMBL8560879 0.85 KDM4E (0.51) HRH3RAB9AALDH1A1MEN1KMT2A
SCHEMBL8562390 0.83 CYP2D6 (0.54) HRH3RAB9AALDH1A1MEN1KMT2A
SCHEMBL16845085 0.83 HRH3 (0.50) HRH3DRD3PAOXRAB9ASLC29A1
SCHEMBL11025698 0.82 HRH3 (0.47) HRH3DRD3PAOXRAB9ASLC29A1
SCHEMBL14641556 0.81 HRH3 (0.49) HRH3DRD3PAOXRAB9ASLC29A1
SCHEMBL24219772 0.80 HRH3 (0.48) HRH3DRD3PAOXRAB9ASLC29A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8877751-B2 Benzothiazolone derivatives MERCK PATENT GMBH (DE) 2014-11-04 US disclosed
EP-2150539-B1 PYRIDAZINONE DERIVATIVES MERCK PATENT GMBH (DE) 2013-12-18 EP disclosed
US-8367668-B2 Pyridazinone derivatives MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 2013-02-05 US disclosed
US-20110269756-A1 BENZOTHIAZOLONE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-11-03 US disclosed
US-20110136819-A1 6-THIOXOPYRIDAZINE DERIVATIVES MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 2011-06-09 US disclosed
US-20100179148-A1 PYRIDAZINONE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2010-07-15 US disclosed
WO-2009024221-A1 6-THIOXO-PYRIDAZINE DERIVATIVES MERCK PATENT GBMH (DE) 2009-02-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179148-A1 PYRIDAZINONE DERIVATIVES MET, ERBB2, RET HRH3 1571/4885DRD3 2521/4885PAOX 3021/4885
US-20110269756-A1 BENZOTHIAZOLONE DERIVATIVES RET, JAK2, MET HRH3 2083/4885DRD3 2820/4885PAOX 3514/4885
US-20110136819-A1 6-THIOXOPYRIDAZINE DERIVATIVES RET, ABL1, JAK2 HRH3 2891/4885DRD3 3168/4885PAOX 3551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.